NCT02634320 - A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions

Schizophrenia

Interventions

DRUG

Aripiprazole Lauroxil

Monthly IM injection

Trial Locations (18)

27711

Alkermes Investigational Site, Little Rock

30901

Alkermes Investigational Site, Augusta

44125

Alkermes Investigational Site, Garfield Heights

60640

Alkermes Investigational Site, Chicago

63141

Alkermes Investigational Site, St Louis

71101

Alkermes Investigational Site, Shreveport

72758

Alkermes Investigational Site, Rogers

75115

Alkermes Investigational Site, DeSoto

75231

Alkermes Investigational Site, Dallas

75243

Alkermes Investigational Site, Dallas

90230

Alkermes Investigational Site, Culver City

91402

Alkermes Investigational Site, Panorama City

91950

Alkermes Investigational Site, National City

92056

Alkermes Investigational Site, Oceanside

92805

Alkermes Investigational Site, Anaheim

92845

Alkermes Investigational Site, Garden Grove

92868

Alkermes Investigational Site, Orange

02865

Alkermes Investigational Site, Lincoln